CONCORD DRUGS
Back to Balance Sheet
|
CONCORD DRUGS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Current Assets | ₹41 Cr | ₹38 Cr | ₹43 Cr | ₹42 Cr |
What is the latest Total Current Assets ratio of CONCORD DRUGS ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹41 Cr |
| Mar2024 | ₹38 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹42 Cr |
How is Total Current Assets of CONCORD DRUGS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹41 Cr | 8.65 | |
| Mar2024 | ₹38 Cr | -13.67 | |
| Mar2023 | ₹43 Cr | 3.74 | |
| Mar2022 | ₹42 Cr | - | |
Compare Total Current Assets of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹94.6 Cr | -1.1% | 1.7% | -6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | -1.1% |
1.7% |
-6.2% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses